Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.
Greiner MG, Shulman M, Opara O, Potter K, Voronca DC, Tafessu HM, Hefner K, Hamilton A, Scheele C, Ho R, Dresser L, Jelstrom E, Fishman M, Ghitza UE, Rotrosen J, Nunes EV, Bisaga A. Greiner MG, et al. Contemp Clin Trials. 2023 May;128:107148. doi: 10.1016/j.cct.2023.107148. Epub 2023 Mar 15. Contemp Clin Trials. 2023. PMID: 36931426 Free PMC article. Clinical Trial.
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder.
Hefner K, Choo TH, Shmueli-Blumberg D, Pavlicova M, King J, Fishman M, Shulman M, Campbell A, Greiner M, Scodes J, Meyers-Ohki S, Novo P, Nunes E, Rotrosen J. Hefner K, et al. Drug Alcohol Depend Rep. 2022 Dec;5:100100. doi: 10.1016/j.dadr.2022.100100. Epub 2022 Sep 29. Drug Alcohol Depend Rep. 2022. PMID: 36644220 Free PMC article.
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.
Shulman M, Greiner MG, Tafessu HM, Opara O, Ohrtman K, Potter K, Hefner K, Jelstrom E, Rosenthal RN, Wenzel K, Fishman M, Rotrosen J, Ghitza UE, Nunes EV, Bisaga A. Shulman M, et al. Among authors: greiner mg. JAMA Netw Open. 2024 May 1;7(5):e249744. doi: 10.1001/jamanetworkopen.2024.9744. JAMA Netw Open. 2024. PMID: 38717773 Free PMC article. Clinical Trial.
Energy Transfer in Stability-Optimized Perovskite Nanocrystals.
Greiner MG, Singldinger A, Henke NA, Lampe C, Leo U, Gramlich M, Urban AS. Greiner MG, et al. Nano Lett. 2022 Aug 24;22(16):6709-6715. doi: 10.1021/acs.nanolett.2c02108. Epub 2022 Aug 8. Nano Lett. 2022. PMID: 35939043
The Stigma of Addiction.
Greiner MG, Dixon LB. Greiner MG, et al. Psychiatr Serv. 2021 Sep 1;72(9):1105-1106. doi: 10.1176/appi.ps.72901. Psychiatr Serv. 2021. PMID: 34465203 No abstract available.
Corrigendum to "Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse" [Journal of Substance Abuse Treatment 131 (2021) 108447].
Greiner MG, Shulman M, Choo TH, Scodes J, Pavlicova M, Campbell ANC, Novo P, Fishman M, Lee JD, Rotrosen J, Nunes EV. Greiner MG, et al. J Subst Abuse Treat. 2022 May;136:108566. doi: 10.1016/j.jsat.2021.108566. Epub 2021 Aug 6. J Subst Abuse Treat. 2022. PMID: 34366203 Free PMC article. No abstract available.
12 results